Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Amthauer

Showing results (161-170 of 197) with videos related to

Pageof 20
Sort By:
European Radiology|November 13, 2015
Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patientsJulian M M Rogasch, Ingo G Steffen, Sandra Riedel, et al.
BMC Cancer|July 15, 2015
Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Max Seidensticker, Benjamin Garlipp, Sophia Scholz, et al.
Onkologie|May 1, 2010
[Specific treatment situations in metastatic colorectal cancer]Dirk Arnold, Hans-Joachim Schmoll, Hauke Lang, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
The Impact of Unilateral <sup>90</sup>Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) StudyBenjamin Garlipp, Holger Amthauer, Dennis Kupitz, et al.
Journal of Neuroendocrinology|November 8, 2025
Systematic review and meta-analysis of the efficacy and safety of [<sup>177</sup>Lu]Lu-edotreotide ([<sup>177</sup>Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumorsRichard P Baum, Julia G Fricke, Tristan Ruhwedel, et al.
Hepatology (Baltimore, Md.)|November 22, 2013
Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolizationBenjamin Garlipp, Thierry de Baere, Robert Damm, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 31, 2021
An optimized imaging protocol for [<sup>99m</sup>Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosisImke Schatka, Anne Bingel, Franziska Schau, et al.
European Journal of Radiology|July 18, 2016
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node stagingJulian M M Rogasch, Ivayla Apostolova, Ingo G Steffen, et al.
EJNMMI Research|June 3, 2021
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolizationOsman Öcal, Juozas Kupčinskas, Egidijus Morkunas, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Pageof 20

Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
European Radiology|November 13, 2015
Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patientsJulian M M Rogasch, Ingo G Steffen, Sandra Riedel, et al.
BMC Cancer|July 15, 2015
Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Max Seidensticker, Benjamin Garlipp, Sophia Scholz, et al.
Onkologie|May 1, 2010
[Specific treatment situations in metastatic colorectal cancer]Dirk Arnold, Hans-Joachim Schmoll, Hauke Lang, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
The Impact of Unilateral <sup>90</sup>Y-radioembolization on Functional Changes in the Contralateral Hepatic Lobe: The Prospective, Open-label RadioEmbolization, Volumetry, and Liver FuncTion Measurements (REVoluTion) StudyBenjamin Garlipp, Holger Amthauer, Dennis Kupitz, et al.
Journal of Neuroendocrinology|November 8, 2025
Systematic review and meta-analysis of the efficacy and safety of [<sup>177</sup>Lu]Lu-edotreotide ([<sup>177</sup>Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumorsRichard P Baum, Julia G Fricke, Tristan Ruhwedel, et al.
Hepatology (Baltimore, Md.)|November 22, 2013
Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolizationBenjamin Garlipp, Thierry de Baere, Robert Damm, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 31, 2021
An optimized imaging protocol for [<sup>99m</sup>Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosisImke Schatka, Anne Bingel, Franziska Schau, et al.
European Journal of Radiology|July 18, 2016
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node stagingJulian M M Rogasch, Ivayla Apostolova, Ingo G Steffen, et al.
EJNMMI Research|June 3, 2021
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolizationOsman Öcal, Juozas Kupčinskas, Egidijus Morkunas, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Pageof 20